GSK’s rising oncology ambitions face headwinds in India, with Natco challenging the validity of the patent underpinning ...
At its capital markets day at the London Stock Exchange earlier this month, Sandoz set out plans to have 100 biosimilars in ...
The agency leveraged subcutaneous semaglutide’s STEP and SELECT data to grant the first GLP-1 obesity pill its weight loss ...
A layer of legal oversight of the US Food and Drug Administration has been removed, potentially giving more freedom to its ...
Oncology accounted for a quarter of all novel application withdrawals over the past decade and accelerated approval is the ...
The company announced positive Phase II data for the BCMA-directed CAR-T therapy in patients with relapsed/refractory AL ...
New proposal from the European Commission will require member states to take a personalized, accessible approach to screening ...
At an upcoming meeting, a Cosmetic Ingredient Review panel is slated to review safety assessments of two prostaglandin ...
Oncology drug development is built to reward tumour shrinkage, yet metastasis kills most patients. Closing this blind spot ...
Louisiana Medicaid likely saved more than $200m by using a hepatitis C “subscription” contract model from 2019 to 2024, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results